People in the earliest stage of Alzheimer’s disease — after brain changes have begun but before cognitive symptoms become apparent — harbor an assortment of bacteria in their intestines that differs from the gut bacteria of healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
An article published in Nature Medicine from neurologists Kanta Horie, PhD, Chihiro Sato, PhD, Nupur Ghoshal, MD, PhD, Randall Bateman, MD, and colleagues has won the International Society to Advance Alzheimer’s Research and Treatment (ISTAART) 2023 Publication of the Year Award. The article is titled, “CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.” […]
The Alzheimer’s Association partnered with Washington University in St. Louis on Thursday, May 4 to explore answers to the question along with other health equity issues related to the disease. The event featured three researchers in St. Louis who aim to improve health equity in research, care, and support. One of those researchers is Dr. Joyce […]
ST. LOUIS, Mo. (KMOV) – The National Headache Foundation estimates nearly 12% of the population experience migraine headaches. But, many people do not know they suffer from this, therefore, it’s never treated. In today’s Living Well, News 4′s Taylor Holt talks to a doctor about how to know if you have them and how you […]
The Department of Neurology’s Cerebral Palsy Center is hosting its inaugural Cerebral Palsy Family Day on June 24, 2023, at the Missouri Botanical Gardens. The event originated when a family previously seen in the Cerebral Palsy (CP) Center provided the center with a generous donation. The donor’s wishes were for caregivers of individuals with CP […]
The Washington University Department of Neurology’s Omar Butt, MD, PhD, Gabriela de Bruin, MD, and Salah Keyrouz, MD, FAHA, were recipients of the 2023 Dean’s Impact Awards for their superior efforts in the face of the COVID-19 pandemic. They demonstrated the highest level of professionalism and delivered exceptional results across the missions of the School […]
Women are about twice as likely as men to be diagnosed with Alzheimer’s disease. Some of that is age; in the U.S., women outlive men by five to six years, and advanced age is the strongest risk factor for Alzheimer’s. But there’s more to it than that, so Alzheimer’s researchers continue to look for other […]
The Department of Neurology congratulates Neurology Clinical Research Coordinator II Alicia Vonderheid for being awarded the Neurology Staff Employee of the Quarter for Q3 FY23. Vonderheid was nominated by faculty and staff because of her exceptional ability to make research participants and their caretakers feel calm and cared for. Those who nominated her, also, highlighted […]
A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS), a paralyzing neurological disease. Known as tofersen, the drug has been shown to slow progression of the deadly disease. International clinical trials of tofersen, developed by the global biotechnology company Biogen Inc., […]
The seemingly simple act of reaching for a cup of coffee requires a lot of effort from the brain. It has to plan a trajectory to the cup, control dozens of muscles, make adjustments based on feedback from the eyes and fingers, and maintain its focus on the goal: a tasty jolt of caffeine. And […]